Fire & Flower Holdings Corp (FFLWF)
0.12
0.00 (0.00%)
USD |
OTCM |
Jun 07, 16:00
Fire & Flower Holdings Shareholders Equity (Quarterly): 43.20M for March 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 43.20M |
| October 31, 2022 | 71.85M |
| July 31, 2022 | 96.26M |
| April 30, 2022 | 112.47M |
| January 31, 2022 | 90.66M |
| October 31, 2021 | 104.44M |
| July 31, 2021 | 94.37M |
| April 30, 2021 | 70.52M |
| January 31, 2021 | 27.91M |
| October 31, 2020 | 1.999M |
| Date | Value |
|---|---|
| July 31, 2020 | 18.22M |
| April 30, 2020 | 36.85M |
| January 31, 2020 | 35.50M |
| October 31, 2019 | 42.07M |
| July 31, 2019 | 30.29M |
| April 30, 2019 | 26.41M |
| November 30, 2018 | 0.6095M |
| August 31, 2018 | 0.6834M |
| May 31, 2018 | 0.3796M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.999M
Minimum
Oct 2020
112.47M
Maximum
Apr 2022
58.44M
Average
43.20M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| InMed Pharmaceuticals Inc | 11.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 108.70M |
| Total Liabilities (Quarterly) | 65.50M |
| Debt to Equity Ratio | 0.2381 |
| Current Ratio | 0.748 |
| Net Debt Paydown Yield | -4.96% |